SCHOTT Pharma AG & Co. KGaA (SHTPY)

Market Cap	2.79B -25.8%
Revenue (ttm)	1.17B +4.2%
Net Income	176.05M +11.8%
EPS	1.16 +11.3%
Shares Out	n/a
PE Ratio	15.88
Forward PE	15.99
Dividend	0.03 (0.65%)
Ex-Dividend Date	Feb 5, 2026

Volume	100
Average Volume	138
Open	4.370
Previous Close	4.500
Day's Range	4.370 - 4.370
52-Week Range	4.370 - 7.650
Beta	0.90
RSI	n/a
Earnings Date	Feb 11, 2026

About SHTPY

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. The company offers syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPAC cosmetic, a polymer syringe for aesthetic treatments; SCHOTT TOPPAC freeze, a polymer syringe for deep-cold application...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1884
• Employees: 4,811
• Stock Exchange: OTCMKTS
• Ticker Symbol: SHTPY

Financial Performance

In fiscal year 2025, SHTPY's revenue was 986.21 million, an increase of 3.04% compared to the previous year's 957.09 million. Earnings were 146.45 million, a decrease of -2.16%.

Financial numbers in EUR